Key Highlights
- Personal Testing revenues up 48% on the prior corresponding period (pcp) driven by both international (up 42%) and domestic testing (up 53%)
- Operational countries up from 4 to 13 YTD, with the addition of Poland, Hungary, Romania, Croatia, Türkiye and Czech Republic during the quarter
- Positive uptake of Microba’s new MetaXplore healthcare test, with >300 Australian healthcare professional accounts registered in the first 7 weeks following launch
- Inflammatory Bowel Disease Program – MAP 315 approved to commence Phase I
- Immuno-Oncology Program – Positive first animal model data
- Autoimmune Disease Program – Positive first in vitro results
- Q3 FY23 unaudited revenue totalled $1.01m, up 61% on the pcp with Personal Testing up 48% to $0.61m and Research Services up 86% to $0.40m
- YTD FY23 unaudited revenue of $3.16m, up 12% on the pcp with Personal Testing up 16% to $1.79m and Research Services up 6% to $1.37m
- Q3 FY23 cash receipts totalling $1.24m, representing 22% growth on the pcp
- YTD FY23 cash receipts totalling $4.65m, representing 45% growth on the pcp
- $35.40 million in cash or equivalents as at 31 March 2023
Not bad at all.
- Forums
- ASX - By Stock
- MAP
- Ann: Q3 FY23 Quarterly Investor Presentation
Ann: Q3 FY23 Quarterly Investor Presentation, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAP (ASX) to my watchlist
|
|||||
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $71.65M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 14.5¢ | $161.3K | 1.045M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 90047 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 331293 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 68980 | 0.150 |
3 | 30586 | 0.145 |
2 | 42147 | 0.140 |
1 | 38316 | 0.130 |
1 | 80000 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 331293 | 3 |
0.180 | 26337 | 1 |
0.185 | 6000 | 1 |
0.190 | 80000 | 1 |
0.195 | 32660 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online